Projects per year
Fingerprint Dive into the research topics where Robert R Mc Williams is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Pancreatic Neoplasms
Medicine & Life Sciences
Melanoma
Medicine & Life Sciences
Adenocarcinoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Single Nucleotide Polymorphism
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2006 2011
- 1 Finished
Molecular Epidemiology
Pancreatic Neoplasms
Research Personnel
DNA Repair
Neoplasms
Research Output 2003 2019
Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine
Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.Research output: Contribution to journal › Article
Colchicine
Fever
Mitogen-Activated Protein Kinases
Familial Mediterranean Fever
Therapeutics
1
Citation
(Scopus)
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
Yadav, S., Xie, H., Bin-Riaz, I., Sharma, P., Durani, U., Goyal, G., Borah, B. J., Borad, M. J., Smoot, R., Roberts, L. R., Go, R. S., Mc Williams, R. R. & Mahipal, A., Jan 1 2019, In : European Journal of Surgical Oncology.Research output: Contribution to journal › Article
Propensity Score
Cholangiocarcinoma
Adjuvant Chemotherapy
Drug Therapy
Survival
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma
Huffman, B. M., Jin, Z., Yadav, S., Patel, S., Nagorney, D. M., Truty, M., Mc Williams, R. R., Halfdanarson, T. R. & Mahipal, A., Jan 1 2019, In : Clinical colorectal cancer.Research output: Contribution to journal › Article
Adenocarcinoma
Survival
Adjuvant Chemotherapy
Monocytes
Neoplasms
13
Citations
(Scopus)
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
Meric-Bernstam, F., Hurwitz, H., Raghav, K. P. S., Mc Williams, R. R., Fakih, M., VanderWalde, A., Swanton, C., Kurzrock, R., Burris, H., Sweeney, C., Bose, R., Spigel, D. R., Beattie, M. S., Blotner, S., Stone, A., Schulze, K., Cuchelkar, V. & Hainsworth, J., Apr 1 2019, In : The Lancet Oncology. 20, 4, p. 518-530 13 p.Research output: Contribution to journal › Article
Colorectal Neoplasms
Therapeutics
Trastuzumab
pertuzumab
Chills
1
Citation
(Scopus)
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status
Antwi, S., Fagan, S. E., Chaffee, K. G., Bamlet, W. R., Hu, C., Polley, E., Hart, S., Shimelis, H., Lilyquist, J., Gnanaolivu, R. D., Mc Williams, R. R., Oberg, A. L., Couch, F. J. & Petersen, G. M., Mar 1 2019, In : Journal of the National Cancer Institute. 111, 3, p. 264-271 8 p.Research output: Contribution to journal › Article
Pancreatic Neoplasms
Mutation
Genes
Confidence Intervals
Neoplasms